These results highlight the novel role of DAX1 in regulating Hh signaling in prostate cancer cells and provide a foundation for future studies aimed at understanding the mechanism of the DAX1-mediated inhibition of GLI activity. This evidence concerns the gene NR0B1 and Familial prostate cancer.